Physician profile
Veronica Nguyen
NPI 1649666579
$2,774.78
in general payments reported to CMS, 2019-2025
11 companies · $646 in 2025
The $646 reported for 2025 was more than what 83% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.44 · 2022: $185 · 2023: $646 · 2024: $1,243 · 2025: $646.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,514 · Education: $20.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,514.27 |
| Education | $20.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $769.18 | 2022-2024 | |
| Gilead Sciences, INC. | $580.22 | 2024-2025 | Livdelzi, Epclusa, Vemlidy |
| Mallinckrodt Hospital Products INC. | $274.11 | 2022-2025 | Terlivaz |
| Ipsen Biopharmaceuticals, INC | $236.43 | 2024-2025 | Iqirvo |
| Boston Scientific Corporation | $225.86 | 2019-2025 | Therasphere Y90 Glass Microspheres 10 Gbq, Accolade Sr |
| United Therapeutics Corporation | $193.14 | 2024-2025 | Remodulin, Orenitram, Tyvaso |
| Olympus America INC. | $155.18 | 2023 | Endoclot Phs, Disposable Grasping Forceps |
| Phathom Pharmaceuticals, INC. | $124.45 | 2024 | Voquezna |
| Ceribell, INC. | $110.00 | 2025 | Pocket Eeg Device |
| Madrigal Pharmaceuticals | $78.90 | 2024 | Resmetirom |
| Bayer Healthcare Pharmaceuticals INC. | $27.31 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Veronica Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.